Cholesterol Metabolite’s Role⁢ in Parkinson’s Disease⁤ Identified

⁤ ‍ Updated June 2, 2025

A new study pinpoints a ⁤cholesterol metabolite’s critical role in the progression of Parkinson’s disease. Researchers at Wuhan ⁤University in China,⁢ led by Zhentao Zhang, found that the metabolite⁤ fuels the advancement of Lewy bodies and the subsequent death of dopamine neurons, both hallmarks ⁣of the disease. Their findings, published ‍Feb. 18 in PLOS Biology, suggest that targeting this metabolite could offer new therapeutic avenues.

Parkinson’s is characterized by the accumulation of alpha-Syn protein into Lewy bodies, which spread throughout the brain and ultimately kill dopamine-producing neurons.‍ The ⁢research team focused on identifying⁢ the trigger for the spread of these pathological alpha-Syn fibers. They hypothesized that 24-OHC, a cholesterol metabolite present at elevated levels in the brains of Parkinson’s patients and known to increase with age, was the key.

The team confirmed elevated ⁤24-OHC levels in the blood of Parkinson’s patients and in a mouse model of the disease. By blocking the enzyme responsible for 24-OHC production‍ in the mice, they observed a reduction in ⁢the⁤ spread of harmful alpha-Syn fibers and less ⁣damage to dopamine neurons. Further experiments showed that adding 24-OHC to neurons in‍ culture caused ‍normal alpha-Syn‍ to transform into harmful ⁢fibers. Injecting mice with these fibers resulted in increased lewy body spread, neuron degeneration, and⁤ motor deficits, compared to mice injected with alpha-Syn fibers formed without 24-OHC.

These results suggest ⁣that drugs preventing the conversion of cholesterol to 24-OHC ‍could be an effective treatment strategy for Parkinson’s disease. The study highlights the⁤ significant role of cholesterol metabolism in the disease process.

Zhang’s team stated that their‍ findings indicate ‍that the⁤ cholesterol 24-hydroxylase CYP46A1 plays a pivotal role ⁣ in the progression of α-synuclein pathology in Parkinson’s disease, highlighting its potential as a therapeutic target for Parkinson’s disease.

What’s ⁣next

Further research will focus on ⁣developing and testing drugs⁣ that can ⁤effectively block the production of 24-OHC, potentially leading to new treatments for parkinson’s disease that target the underlying mechanisms of the disease.